Wesołowska, O.; Michalak, K.; Błaszczyk, M.; Molnár, J.; Środa-Pomianek, K.
Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells. Molecules 2020, 25, 1654.
https://doi.org/10.3390/molecules25071654
AMA Style
Wesołowska O, Michalak K, Błaszczyk M, Molnár J, Środa-Pomianek K.
Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells. Molecules. 2020; 25(7):1654.
https://doi.org/10.3390/molecules25071654
Chicago/Turabian Style
Wesołowska, Olga, Krystyna Michalak, Maria Błaszczyk, Joseph Molnár, and Kamila Środa-Pomianek.
2020. "Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells" Molecules 25, no. 7: 1654.
https://doi.org/10.3390/molecules25071654
APA Style
Wesołowska, O., Michalak, K., Błaszczyk, M., Molnár, J., & Środa-Pomianek, K.
(2020). Organosilicon Compounds, SILA-409 and SILA-421, as Doxorubicin Resistance-Reversing Agents in Human Colon Cancer Cells. Molecules, 25(7), 1654.
https://doi.org/10.3390/molecules25071654